Abstract
Tuberculosis has once again emerged as a significant public health problem in Western countries. Much of the rise has been fueled by the growing numbers of persons infected with HIV. Co-infection withMycobacterium tuberculosis and HIV has been shown to result in high rates of active tuberculosis, and possibly in acceleration of progression to AIDS. Primary tuberculosis occurs at high rates among dually infected persons, further emphasizing the need for effective isolation of infectious cases. Recent preliminary studies have demonstrated that the survival of persons with multidrug-resistant tuberculosis can be six months and longer, far in excess of the 4 to 12 weeks reported previously. At least seven health care workers have died of occupationally-acquired multidrug-resistant tuberculosis, making control of the spread of tuberculosis in health care settings an urgent public health priority.
Similar content being viewed by others
References
Brudney K, Dobkin J Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. American Review of Respiratory Disease 1992, 44: 745–749.
Bloom BR, Murray CJL Tuberculosis: commentary on a reemergent killer. Science 1992, 257: 1055–1064.
Ellner JJ, Hinman AR, Dooley SW, Fischl M, Sepkowitz KA, Goldberger MJ, Shinnick TM, Iseman MD, Jacobs WR Infectious Disease Society of America Symposium: tuberculosis — emerging problems and promise. Journal of Infectious Diseases 1993, 168: 537–551.
Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine 1993, 328: 521–526.
Centers for Disease Control Tuberculosis morbidity in the United States: final data. Morbidity and Mortality Weekly Report 1992, 41: 240.
Centers for Disease Control Tuberculosis — Western Europe, 1974–1991. Morbidity and Mortality Weekly Report 1993, 42: 628–631.
DeCock KM, Soro B, Coulibaly IM, Lucas SB Tuberculosis and HIV infection in Sub-Saharan Africa. Journal of the American Medical Association 1992, 268:1581–1587.
Centers for Disease Control Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons — Florida and New York. Morbidity and Mortality Weekly Report 1991, 40: 585–591.
Fischl MA, Uttamhandani RB, Daikos GL, Poblete RB, Moreno JN, Reyes RR, Boota AM, Thompson LM, Cleary TJ, Lai S An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Annals of Internal Medicine 1992, 117: 177–183.
Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sardillo EM, Ong KR, Kilburn JO, Dooley SW, Castro KG, Jarvis WR, Holmberg SD An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 1992, 326: 1514–1521.
Pearson ML, Jareb JA, Frieden TR, Crawford JT, Davis BJ, Dooley SW, Jarvis WR Nosocomial transmission of multidrug-resistantMycobacterium tuberculosis. Annals of Internal Medicine 1992, 117: 191–196.
Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullan JV, Jarvis WR, Bloch AB, Cauthen GM Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. Journal of the American Medical Association 1992, 267: 2632–2635.
Stead WW Pathogenesis of the sporadic case of tuberculosis. New England Journal of Medicine 1967, 277: 1008–1012.
Stead WW Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals or of the primary infection or exogenous reinfection? American Reviews of Respiratory Disease 1967, 95: 729–745.
Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Hopewell PC An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment length polymorphisms. New England Journal of Medicine 1992, 326: 231–235.
Small P, Shafer RW, Hopewell P, Singh S, Murphy M, Desmond E, Sierra M, Schoolnik G Exogenous reinfection with multidrug-resistant mycobacterium tuberculosis in patients with advanced HIV infection. New England Journal of Medicine 1993, 328: 1137–1144.
Raleigh JW, Wichelhausen RH, Rado TA, Bates JH Evidence for infection by two distinct strains ofMycobacterium tuberculosis in pulmonary tuberculosis: report of 9 cases. American Reviews of Respiratory Disease 1975, 112: 497–503.
Ormerod P, Skinner C Reinfection tuberculosis: two cases in the family of a patient with drug-resistant disease. Thorax 1980, 35: 56–59.
Nardell E, McInnis B, Thomas B, Weidhaas S Exogenous reinfection with tuberculosis in a shelter for the homeless. New England Journal of Medicine 1986, 315: 1570–1575.
Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer AM, Reider HL, Schopfer K, Bodmer T Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993, 342: 841–844.
Kin SJ, Hong YP Drug resistance ofMycobacterium tuberculosis in Korea. Tubercle and Lung Disease 1992, 73: 219–224.
Centers for Disease Control National action plan to combat multidrug-resistant tuberculosis. Morbidity and Mortality Weekly Report 1992, 41 (RR-11): 1–71.
Selwyn P, Hartel D, Lewis V, Schoenbaum EE, Vermond S, Klein R, Walker AT, Friedland GH A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine 1989, 320: 545–550.
Di Perri G, Danzi MC, DeChecci G, Pizzighella S, Solbrati M, Cruciani M, Luzzati R, Molena M, Mazzi R, Concia E, Bassetti D Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989, 2: 1502–1504.
Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo M, Scavotto RT, Astemborski J, Vlahov D Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and-seronegative intravenous drug users. Journal of the American Medical Association 1992, 267: 369–373.
Moreno S, Baraia-Etxaburu J, Bouza E, Parras F, Perez-Tascon M, Mirrales P, Vicente T, Alberdi JC, Cosin J, Lopez-Gay D Risk for developing tuberculosis among anergic patients infected with HIV. Annals of Internal Medicine 1993, 119: 194–198.
Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. Journal of the American Medical Association 1992, 268: 504–509.
Peloquin CA, MacPhee AA, Berning SE Malabsorption of antimycobacterial medications. New England Journal of Medicine 1993, 329: 1122–1123.
Slutsker L, Castro KG, Ward JW, Dooley SW Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. Clinical Infectious Diseases 1993, 16: 513–518.
Sepkowitz KA, Telzak EE, Carrow M, Armstrong D Fever among outpatients with advanced HIV infection. Archives of Internal Medicine 1993, 153: 1909–1912.
Kramer F, Modilevsky T, Waliany AR, Leedom JM, Barnes PF Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. American Journal of Medicine 1990, 89: 451–456.
Wallis RS, Vjecha M, Amir-Tahmasseb M, Okwera A, Byekwaso F, Nyole J, Kabengera J, Mugerwa RD, Ellner JJ Influence of tuberculosis on HIV: enhanced cytokine expression and elevated beta-2-microglobulin in HIV-1 associated tuberculosis. Journal of Infectious Diseases 1992, 167: 43–48.
Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. Journal of Experimental Medicine 1993, 177: 1511–1516.
Pape JW, Simone SS, Ho JL, Hafner A, Johnson WD Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 342: 268–272.
Fischl MA, Daikos GL, Uttamchandani RB, Poblete RB, Moreno JN, Reyes RR, Boota AM, Thompson LM, Cleary TJ, Oldham SA, Saldana MJ, Lai S Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Annals of Internal Medicine 1992, 117: 184–190.
Iseman MD Treatment of multidrug-resistant tuberculosis. New England Journal of Medicine 1993, 329: 784–791.
Perriens J, Colebunders R, Darahunga C, Willame JC, Jeugmans J, Kaboto M, Mukadi Y, Pauwels P, Ryder RW, Prignot J, Piot P Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive patients compared with HIV seronegative patients with pulmonary tuberculosis treated with standard therapy in Zaire. American Reviews of Respiratory Diseases 1991, 144: 750–755.
Sunderam G, Mangura B, Lombardo L, Reichman L Failure of optimal four-drug short-course tuberculosis chemotherapy in a compliant patient with human immunodeficiency virus. American Reviews of Respiratory Diseases 1987, 136: 1475–1478.
Daley CL Tuberculosis recurrence in Africa: true relapse or re-infection. Lancet 1993, 342: 756–757.
Sepkowitz KA Tuberculosis and the health care worker: a historical perspective. Annals of Internal Medicine 1994, 120: 71–79.
Dooley S, Castro K, Hutton M, Mullan R, Polder J, Snider D Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. Morbidity and Mortality Weekly Report 1990, 39 (RR-17):1–29.
Centers for Disease Control Draft guidelines for preventing the transmission of tuberculosis in healthcare facilities. Federal Register 1993, 58: 52810–52854.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sepkowitz, K.A., Raffalli, J. Tuberculosis at the end of the twentieth century. Eur. J. Clin. Microbiol. Infect. Dis. 13, 902–907 (1994). https://doi.org/10.1007/BF02111490
Issue Date:
DOI: https://doi.org/10.1007/BF02111490